News | September 22, 2023
Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The market capitalization of the company stood at Rs. 7,000 crore +
Apollo Telehealth has established more than 700 centers, in 7 states
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Subscribe To Our Newsletter & Stay Updated
